Alerts

New conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.

Consumers and health professionals are advised that Janssen-Cilag (Australia), in consultation with the TGA, is deregistering and discontinuing supply of oral ketoconazole (Nizoral) 200 mg tablets, commencing 1 December 2013.

Unlocated devices following recall for product correction.

Changes to radio frequency (RF) spectrums in Australia could affect a small number of biomedical telemetry devices used in hospitals.

Recall for product correction due to potential for aluminium tubing to break.

Recall for product correction due to potential for injury.

TGA safety alert providing guidance for consumers on apixaban, dabigatran and rivaroxaban, highlighting the risk of bleeding, safe use, and the importance of not stopping treatment without medical advice.

TGA safety alert for health professionals on apixaban, dabigatran and rivaroxaban emphasises bleeding risks, careful patient selection, renal function assessment, and adherence to prescribing guidelines.

Recall for product correction due to potential for handle to break.

Recall due to replacement with newer model.

A hazard alert has been issued to cardiologists and surgeons regarding some models of Cognis Cardiac Resynchronisation Therapy Defibrillators (CRT-Ds) and Teligen Implantable Cardioverter Defibrillators (ICDs).

Blue Stinger capsules pose a serious health risk and should not be taken. They contain undeclared sulfoaildenafil and have not been assessed for quality, safety or efficacy.

Hazard alert due to updated surgical instructions and additional quality check.

Consumers and health professionals are advised that LMT Surgical is issuing a hazard alert for all sizes and lots of its PyroTitan humeral resurfacing arthroplasty device.

It has been identified that there is a potential for some screws from the affected lot to break during insertion or removal.

Maximum Powerful tablets pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.

Consumers and health professionals are advised that Aimedics, in consultation with the TGA, is recalling from the market all units of its HypoMon sleep-time hypoglycaemic monitor.

Hazard alert due to potential for breakage.

Zimmer is recalling from the market for the purpose of relabelling unused stock of its NexGen micro implants.

Boston Scientific has initiated a recall for product correction for multiple lots of its Promus Element Plus Monorail everolimus-eluting coronary stent system.

Consumers, health professionals and suppliers are advised that Ascent Pharmaceuticals, in consultation with the TGA, are recalling one batch of Febridol Paracetamol 500 mg 100 tablet bottles.

UPMAX capsules pose a serious risk to your health and should not be taken. They contain undeclared sulfoaildenafil and have not been assessed by the TGA for quality, safety or efficacy.

Recall due to potential gas leak.

MSS Maximum Sexual Stimulant tablets pose a serious risk to your health and should not be taken. They contain undeclared sulfohydroxyhomosildenafil and have not been assessed for quality, safety or efficacy.

Novo Nordisk Pharmaceuticals has initiated a recall for product correction of certain lots of its NordiPen medical device.